News

Bilendi Reports Major Revenue Growth Amid Market Challenges

Bilendi Reports Major Revenue Growth Amid Market Challenges

Bilendi's Impressive First-Half Revenue Growth

Bilendi, a global leader in technology and AI solutions for market research, has reported a remarkable revenue of €43.5 million for the first half of 2025. This represents an inspiring increase of 42.2%, showcasing a significant turnaround in performance amid challenging sector conditions.

Acquisition of Netquest Enhances Performance

The notable revenue boost includes contributions from Netquest, integrated into Bilendi's operations since February 2025. The company anticipates that this strategic acquisition will strengthen Bilendi's position in the industry and enhance its growth trajectory moving forward.

Pro Forma Revenue Analysis

Examining Bilendi's growth on a pro forma basis reveals an overall growth of 1.4% at constant exchange rates when considering the complete inclusion of Netquest’s activities since January 2024. This insight highlights Bilendi's ability to adapt and thrive in a competitive landscape.

Explosive Growth in International Markets

Bilendi's international revenue has surged by an impressive 55% during the half-year period, reaching €36.4 million, with strong growth across various regions including the Netherlands, Italy, and the DACH region—Germany, Switzerland, and Austria.

Performance in the French Market

In France, Bilendi's revenue showcased a moderate increase of 0.2%, amounting to €7.1 million. Following a slight downturn in the first quarter, the second quarter rebounded, highlighting the firm’s resilience and positive sales momentum.

Strategic Innovations and Developments

Bilendi is not merely relying on numbers; the company is actively enhancing its operations and market strategies through various innovations. It is ambitiously expanding its proprietary panel coverage, aiming to establish new panels across numerous countries with a growth timeline of reaching 50 countries by the end of the year.

Introduction of the Bilendi Platform

One of the cornerstones of Bilendi’s growth is the introduction of the Bilendi Platform, a self-service solution designed to simplify market research management. This tool allows users to conduct research autonomously or with assistance, appealing to the evolving needs of today’s clients for efficiency and flexibility.

AI-Driven Solutions for Market Research

Bilendi has also unveiled Bilendi Discuss, an AI-enhanced market research software that automates significant portions of the research process. With features like automatic report generation powered by their proprietary Bilendi Artificial Research Intelligence (BARI), this innovation represents a significant shift in how market research can be conducted.

20 Years of Growth and Innovation

2025 marks a monumental year for Bilendi, celebrating its 20th anniversary as a publicly listed entity. Originally listed on the Euronext Growth market under the name Maximiles, the company has successfully transformed from its initial focus on online loyalty programs to becoming a global leader in data technology and AI solutions.

Future Objectives and Growth Plans

As Bilendi looks ahead, it reaffirms its goal of attaining €100 million in revenue by 2026, with an EBITDA margin targeting between 20% and 25%. This ambitious roadmap outlines the company's commitment to sustained growth and continual improvement in profitability.

Conclusion

With strong revenue performance, innovative strategies, and substantial international growth, Bilendi is poised to maintain its competitive edge in the rapidly evolving market research landscape. The company’s forward-looking vision, supported by a robust operational strategy, positions it well as a leader in the industry.

Frequently Asked Questions

What were Bilendi's revenues for the first half of 2025?

Bilendi reported revenues of €43.5 million for the first half of 2025, marking an increase of 42.2% compared to the previous year.

How has the acquisition of Netquest impacted Bilendi?

The acquisition of Netquest has been significant, contributing to overall revenue growth and enhancing Bilendi's market presence globally.

What growth did Bilendi experience in international markets?

Bilendi experienced a 55% increase in international revenue, reaching €36.4 million, showcasing strong performance across various regions.

What innovative solutions has Bilendi introduced?

Bilendi launched the Bilendi Platform and Bilendi Discuss, utilizing AI to streamline market research and improve user experiences.

What are Bilendi's future revenue goals?

Bilendi aims to achieve €100 million in revenue by 2026, maintaining an EBITDA margin of 20% to 25%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 98

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

VENU Embraces Blockchain: A New Era for Live Events

Updated Category News Views 203

VENU's Groundbreaking Blockchain Initiative in Live Entertainment In a significant move that signals the future of live entertainment, VENU (NYSE American: VENU), a leading operator of premium venues across the country, has announced an innovative blockchain-powered platform set to launch in 2026. This strategy is revolutionary, intending to blend physical experiences...

Continue Reading
Empowering Leadership Transitions at Ora Enhance Customer Focus

Updated Category News Views 144

Empowering Strategic Leadership at Ora Ora, an esteemed player in the field of ophthalmic contract research organizations (CROs), has recently appointed Cindy Markham as its new Chief Commercial Officer. This strategic move underscores Ora's dedication to enhancing the customer experience, setting a new benchmark in the ophthalmic research sector. Commitment to Customer...

Continue Reading
Real Matters Announces Online Annual General Meeting Details

Updated Category News Views 166

Virtual Annual General Meeting Scheduled for Shareholders Real Matters Inc., a prominent network management services provider, has announced the date for its upcoming Annual General Meeting (AGM). The meeting is set to take place on a Thursday morning, providing a convenient option for shareholders to participate from the comfort of their homes. Accessing the AGM Online...

Continue Reading
Trinity Biotech Triumphs in Nasdaq Compliance Journey

Updated Category News Views 41

Trinity Biotech Celebrates Nasdaq Compliance Achievement Trinity Biotech plc (Nasdaq Global Select: TRIB), a leading name in biotechnology focused on human diagnostics and diabetes management solutions, including innovative wearable biosensors, has reached a significant milestone. The company recently announced it has regained compliance with the minimum market value of...

Continue Reading
Vaycaychella Transitions to Great Estate Blockchains Inc

Updated Category News Views 176

Vaycaychella Unveils a Bold New Identity Vaycaychella, Inc. (OTC Pink: VAYK) has officially announced a name change to "Great Estate Blockchains Inc." This transition signifies a rejuvenated focus on enhancing the value of historic landmarks through innovative cryptocurrency strategies. The company aims to tap into a colossal market, potentially valued in the hundreds of...

Continue Reading